FIELD: chemistry.
SUBSTANCE: described are the bonds of the formula 
of pharmaceutical acceptable salt. The bonds possess an inhibiting action in the relation to beta-tryptase. Also, described is the method to treat patients suffering or subject to physiological diseases, with which it is necessary to increase the level of the inhibitor of tryptase.
EFFECT: bonds increase the level of the inhibitor of tryptase.
13 cl, 3 ex, 2 dwg
| Title |
Year |
Author |
Number |
| [4-(5-AMINOMETHYL-2-FLOUROPHENYL)-PYPERIDIN-1-YL]-(7- FLUORO-1-(2-METHOXYETHYL)-4-TRIFLUOROMETHOXY-1H-INDOL-3-YL]-METHANONE AS MAST CELL TRYPTASE INHIBITOR |
2009 |
- Choi-Sledeski Jong Mi
- Choj Nakien
- Poli Gregori Bernard
- Shej Dzhon Dzh. Ml.
- Shum Patrik Vai-Kvok
- Sledeski Adam V.
|
RU2509766C2 |
| (2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-2-HYDROXYMETHYL-2-METHYLPENTANOIC ACID |
2016 |
- Hughes Adam D.
- Fenster Erik
- Fleury Melissa
- Beausoleil Anne-Marie
- Thalladi Venkat R.
- Nzerem Jerry
- Rapta Miroslav
|
RU2726623C2 |
| 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE, THERAPEUTIC USES THEREOF |
2013 |
- Kollins Yan
- Mettyus Tomas Piter
- Fariya Da Fonseka Makkhardi Tatyana
- Ozborn Dzhejms
- Lejnchbari Majkl
- Uolton Majkl Yan
- Garrett Mishel Doun
|
RU2659786C2 |
| 1-((3S,4R)-4-(3-FLUOROPHENYL)-1-(2-METHOXYETHYL)PYRROLIDIN-3-YL)-3-(4-METHYL-3-(2-METHYLPYRIMIDIN-5-YL)-1-PHENYL-1N-PYRAZOL-5-YL)UREA AS A TRKA KINASE INHIBITOR |
2015 |
- Allen Shelli
- Endryus Stiven U.
- Baer Brajan
- Krejn Zekeri
- Lyu Vejdun
- Uotson Deniel Dzhon
|
RU2719489C2 |
| (2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYLOXAZOLE-2-CARBONYL)AMINO]PENTANOIC ACID |
2016 |
- Fleury Melissa
- Hughes Adam D.
- Beausoleil Anne-Marie
- Fenster Erik
- Thalladi Venkat R.
- Rapta Miroslav
|
RU2715241C2 |
| 2-(3,4-DIMETHYLPHENYL)-4-{[2-HYDROXY-3'-(1H-TETRAZOLE-5-YL)BIPHENYL-3- YL]HYDRAZONO}-5-METHYL-2,4-DIHYDROPYRAZOLE-3-ONE-CHOLINE |
2004 |
- Bruk Kristofer S.
- Pin Li-Tszen Ts.
|
RU2379297C2 |
| 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS |
2009 |
- Patterson Lori Dzhin
- Stehndzhlehnd Ehrik L.
- Tsipfel' Shejla
- Long Dehniel D.
|
RU2515612C2 |
| CRYSTALLINE (2S,4R)-5-(5'-CHLOR-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOL-5-CARBOXAMIDO)-2-METHYLPENTANIC ACID AND ITS APPLICATIONS |
2017 |
- Hughes, Adam D.
- Fleury, Melissa
- Rapta, Miroslav
- Thalladi, Venkat R.
- Fass, Gene Timothy
- Simeone, Michael
- Baldwin, R. Michael
- Bourdet, David L.
|
RU2756223C2 |
| SUBSTITUTED DERIVATIVES OF N-[2-(4-PHENOXYPIPERIDINE-1-YL)-2-(1,3-THIAZOLE-5-YL)ETHYL]BENZAMIDE AND N-[2-(4-BENZYLOXYPIPERIDINE-1-YL)-2-(1,3-THIAZOLE-5-YL)ETHYL]BENZAMIDE AS P2X7 RECEPTOR ANTAGONISTS |
2017 |
- Pevarello Paolo
- Prandi Adolfo
|
RU2755705C2 |
| 1-[[2-(2,2,2-TRIFLUORETHOXY)PYRIDE-4-YL]METHYL]UREA DERIVATIVES AS KCNQ POTENTIATORS |
2020 |
- Szekeres, Helen, Jane
- Whatton, Maria, Ann
- Williams, Andrew, Caerwyn
|
RU2790174C1 |
